FABENCOV Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for FABENCOV with the United States Patent and Trademark Office. The USPTO has given the FABENCOV trademark a serial number of 79324607. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Fabentech. The FABENCOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary products, namely, pharmaceutical and veterinary preparations for the treatment of viral infections diseases particularly, coronavirus disease; pharmaceuticals for immunotherapy particularly, coronavirus disease; diagnostic kits composed primarily of monoclonal antibodies for pharmaceutical and veterinary use for use in disease testing particularly, coronavirus disease; medicines for human medicine or veterinary use, namely, pharmaceutical and veterinary preparations for the treatment of viral infections and infectious diseases particularly, coronavirus disease; vaccines for the prevention of diseases particularly, coronavirus disease; antibodies for pharmaceutical and veterinary use, namely, antitoxic sera and parasiticides; medical plasters; materials for dressings, namely, gauze; medicated baths preparations
fabencov

General Information


Serial Number79324607
Word MarkFABENCOV
Filing DateThursday, September 16, 2021
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6976325
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Goods and ServicesPharmaceutical and veterinary products, namely, pharmaceutical and veterinary preparations for the treatment of viral infections diseases particularly, coronavirus disease; pharmaceuticals for immunotherapy particularly, coronavirus disease; diagnostic kits composed primarily of monoclonal antibodies for pharmaceutical and veterinary use for use in disease testing particularly, coronavirus disease; medicines for human medicine or veterinary use, namely, pharmaceutical and veterinary preparations for the treatment of viral infections and infectious diseases particularly, coronavirus disease; vaccines for the prevention of diseases particularly, coronavirus disease; antibodies for pharmaceutical and veterinary use, namely, antitoxic sera and parasiticides; medical plasters; materials for dressings, namely, gauze; medicated baths preparations
Pseudo MarkFABEN COV

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFabentech
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameFabentech
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameFabentech
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Monday, June 12, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 17, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 17, 2023FINAL DISPOSITION PROCESSED
Sunday, May 14, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Monday, December 12, 2022NOTIFICATION PROCESSED BY IB
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 21, 2022EXAMINER'S AMENDMENT ENTERED
Friday, October 21, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 21, 2022EXAMINERS AMENDMENT E-MAILED
Friday, October 21, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 16, 2022REFUSAL PROCESSED BY IB
Wednesday, April 27, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 27, 2022REFUSAL PROCESSED BY MPU
Thursday, March 17, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 16, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 15, 2022ASSIGNED TO EXAMINER
Tuesday, November 9, 2021APPLICATION FILING RECEIPT MAILED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB